# Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

Study · id `cardio:ct-nct05910125` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05910125](<https://clinicaltrials.gov/study/NCT05910125>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05910125

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 472 participants.

## Technical summary

Registry record NCT05910125. Randomized; single masking; primary purpose treatment. Start 2023-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 472 participants (planned count; ClinicalTrials.gov record NCT05910125, source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)
- Planned start: 2023-07 (anticipated) (ClinicalTrials.gov record NCT05910125, source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05910125, source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05910125, source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05910125, source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05910125-2023-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
- Acronym: AGREE
- Condition: Ischemic Stroke
- Intervention (Drug): Aspirin
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Alteplase
- Lead sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (`cardio:org-sun-yat-sen-memorial-hospital-of-sun-yat-sen-university`)

## Provenance

Content hash: 6c56fd7631e3d9d87bed8d1a757c77aac02f1de8c4b9b8bcee234282d421ce63
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
